Biology of Vascular Malformations of the Brain
- 1 December 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 40 (12), e694-702
- https://doi.org/10.1161/strokeaha.109.563692
Abstract
Background and Purpose—This review discusses recent research on the genetic, molecular, cellular, and developmental mechanisms underlying the etiology of vascular malformations of the brain (VMBs), including cerebral cavernous malformation, sporadic brain arteriovenous malformation, and the arteriovenous malformations of hereditary hemorrhagic telangiectasia.Summary of Review—The identification of gene mutations and genetic risk factors associated with cerebral cavernous malformation, hereditary hemorrhagic telangiectasia, and sporadic arteriovenous malformation has enabled the development of animal models for these diseases and provided new insights into their etiology. All of the genes associated with VMBs to date have known or plausible roles in angiogenesis and vascular remodeling. Recent work suggests that the angiogenic process most severely disrupted by VMB gene mutation is that of vascular stabilization, the process whereby vascular endothelial cells form capillary tubes, strengthen their intercellular junctions, and recruit smooth muscle cells to the vessel wall. In addition, there is now good evidence that in some cases, cerebral cavernous malformation lesion formation involves a genetic 2-hit mechanism in which a germline mutation in one copy of a cerebral cavernous malformation gene is followed by a somatic mutation in the other copy. There is also increasing evidence that environmental second hits can produce lesions when there is a mutation to a single allele of a VMB gene.Conclusions—Recent findings begin to explain how mutations in VMB genes render vessels vulnerable to rupture when challenged with other inauspicious genetic or environmental factors and have suggested candidate therapeutics. Understanding of the cellular mechanisms of VMB formation and progression in humans has lagged behind that in animal models. New knowledge of lesion biology will spur new translational work. Several well-established clinical and genetic database efforts are already in place, and further progress will be facilitated by collaborative expansion and standardization of these.This publication has 93 references indexed in Scilit:
- Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial CellsPublished by Elsevier BV ,2009
- Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 proteinHuman Mutation, 2009
- Regulation of cardiovascular development and integrity by the heart of glass–cerebral cavernous malformation protein pathwayNature Medicine, 2009
- The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPasesNature Medicine, 2009
- Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in miceProceedings of the National Academy of Sciences of the United States of America, 2008
- KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell–cell junctionsThe Journal of cell biology, 2007
- pak2a mutations cause cerebral hemorrhage in redhead zebrafishProceedings of the National Academy of Sciences of the United States of America, 2007
- A βPix–Pak2a signaling pathway regulates cerebral vascular stability in zebrafishProceedings of the National Academy of Sciences of the United States of America, 2007
- PDCD10 Interacts with Ste20-related Kinase MST4 to Promote Cell Growth and Transformation via Modulation of the ERK PathwayMolecular Biology of the Cell, 2007
- Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3The Journal of cell biology, 2006